Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
H&Q Healthcare Investors: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
H&Q Healthcare Investors
H&Q Healthcare Investors
Active
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Apr 3, 2014
Neurovance
$6.3M Series A Extension
—
Tim Barberich
,
GBS Venture Partners
,
Hambrecht & Quist Capital Management
,
Novartis
,
State of Wisconsin Investment Board
,
Venture Investors
Feb 1, 2013
CardioKinetix
$23.0M Series E
—
Johnson & Johnson Innovation
,
New Leaf Venture Partners
,
Saints Capital
,
SV Health Investors
,
Third Rock Ventures
,
VantagePoint Capital Partners
,
H&Q Life Sciences Investors
, J.P. Morgan
, Rod Ferguson
,
SV Health Investors
,
U.S. Venture Partners
Jan 1, 2013
Labcyte
$5.0M Series D
Rafael Torres
Abingworth
,
Advanced Technology Ventures
,
GE Ventures
,
Lightspeed Venture Partners
,
Longwood Fund
,
Polaris Partners
,
Alloy Ventures
,
Cross Atlantic Partners
,
Delphi Ventures
,
H&Q Life Sciences Investors
Oct 18, 2012
Neurovance
$7.0M Series A
Novartis
Tim Barberich
,
GBS Venture Partners
,
H&Q Life Sciences Investors
,
State of Wisconsin Investment Board
,
Venture Investors
Sep 1, 2011
CardioKinetix
$21.0M Series E
New Leaf Venture Partners
, Paul LaViolette
Johnson & Johnson Innovation
,
Saints Capital
,
SV Health Investors
,
Third Rock Ventures
,
U.S. Venture Partners
,
VantagePoint Capital Partners
, J.P. Morgan
Mar 9, 2011
Euthymics Bioscience
$4.0M Series A Extension
Novartis
,
Venture Investors
Tim Barberich
,
GBS Venture Partners
,
H&Q Life Sciences Investors
Mar 1, 2011
Veniti
$14.0M Series A
Baird Capital
,
H&Q Healthcare Investors
, Frank Gentile
Okapi Venture Capital
,
Prolog Ventures
,
St. Louis Arch Angels